MABS519-AF647 Sigma-AldrichAnti-P40 Antibody, clone 11F12.1, Alexa Fluor® 647
This Alexa Fluor® 647 conjugated Anti-P40 Antibody, clone 11F12.1, is validated for use in Immunocytochemistry (IHC) for the detection of P-40.
More>> This Alexa Fluor® 647 conjugated Anti-P40 Antibody, clone 11F12.1, is validated for use in Immunocytochemistry (IHC) for the detection of P-40. Less<<Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
Species Reactivity | Key Applications | Host | Format | Antibody Type |
---|---|---|---|---|
H, M | ICC | M | AlexaFluor®647 | Monoclonal Antibody |
References |
---|
Product Information | |
---|---|
Format | AlexaFluor®647 |
Presentation | Purified mouse conjugate antibody in PBS with 15 mg/ml BSA and 0.1 sodium azide. |
Quality Level | MQ100 |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Storage and Shipping Information | |
---|---|
Storage Conditions | Stable for 1 year at 2-8°C from date of receipt. |
Packaging Information | |
---|---|
Material Size | 100 µL |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
MABS519-AF647 | 04055977275247 |
Documentation
Anti-P40 Antibody, clone 11F12.1, Alexa Fluor® 647 SDS
Title |
---|
Anti-P40 Antibody, clone 11F12.1, Alexa Fluor® 647 Certificates of Analysis
Title | Lot Number |
---|---|
Anti-P40, clone 11F12.1, Alexa Fluor® 647 - 3156731 | 3156731 |
Anti-P40, clone 11F12.1, Alexa Fluor® 647 - 3389929 | 3389929 |
Anti-P40, clone 11F12.1, Alexa Fluor® 647 - 3986256 | 3986256 |
Anti-P40, clone 11F12.1, Alexa Fluor® 647 -Q2592815 | Q2592815 |
Brochure
Title |
---|
New Products Flyer- Vol 4 Signaling Feature- NEW! Phosphohistidine Antibody |
Technical Info
Title |
---|
Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System |
White Paper: Further considerations of antibody validation and usage. |
Posters
Title |
---|
Post-Translational Modifications |